S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CortexymeEditas MedicineSpringWorks TherapeuticsAlectorOrchard Therapeutics
SymbolNASDAQ:CRTXNASDAQ:EDITNASDAQ:SWTXNASDAQ:ALECNASDAQ:ORTX
Price Information
Current Price$59.25$25.13$33.61$30.30$12.18
52 Week RangeHoldHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$34.25$37.33$35.50$27.00$26.20
% Upside from Price Target-42.19% downside48.56% upside5.62% upside-10.89% downside115.11% upside
Trade Information
Market Cap$1.62 billion$1.35 billion$1.41 billion$2.06 billion$1.21 billion
BetaN/A2.65N/AN/A-0.99
Average Volume142,225641,57364,690949,770213,231
Sales & Book Value
Annual RevenueN/A$31.94 millionN/A$27.51 million$2.08 million
Price / SalesN/A40.36N/A75.91563.27
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/A$4.94 per shareN/AN/A$3.63 per share
Price / BookN/A5.09N/A∞3.36
Profitability
Net Income$-12,480,000.00$-109,950,000.00N/A$-52,250,000.00$-230,490,000.00
EPSN/A($2.33)N/A($4.62)($10.22)
Trailing P/E Ratio0.00N/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-842.47%N/A-378.57%N/A
Return on Equity (ROE)-58.22%-56.53%N/A-58.27%N/A
Return on Assets (ROA)-26.73%-31.70%N/A-21.31%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.06%N/A0.19%0.07%
Current Ratio20.30%5.08%33.79%6.57%8.88%
Quick Ratio20.30%5.08%33.79%6.56%8.88%
Ownership Information
Institutional Ownership Percentage21.53%84.74%72.70%52.32%65.25%
Insider Ownership Percentage12.40%0.94%N/A34.40%N/A
Miscellaneous
Employees161335291180
Shares Outstanding26.85 million51.30 million43.01 million68.92 million96.19 million
Next Earnings Date2/25/2020 (Estimated)2/26/2020 (Confirmed)2/25/2020 (Estimated)3/24/2020 (Estimated)2/27/2020 (Confirmed)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel